Pacific Biosciences of Ca... (PACB)
1.35
0.04 (2.66%)
At close: Mar 04, 2025, 9:55 AM
Pacific Biosciences of California Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| Net Income | -306.74M | -314.25M | -181.22M | 29.4M | -84.13M | -102.56M | -92.19M | -74.38M | -31.7M | -66.16M | -79.29M | -94.47M | -109.39M | -140.17M | -87.7M | -43.75M | -21.52M |
| Depreciation & Amortization | 26.53M | 17.32M | 11.59M | 9.3M | 9.95M | 7.21M | 8.44M | 3.88M | 3.68M | 4.22M | 5.65M | 6.65M | 5.8M | 5.16M | 4.1M | 2.99M | 1.58M |
| Stock-Based Compensation | 72.12M | 78.61M | 80.73M | 17.53M | 16.4M | 23.15M | 20.35M | 19.56M | 13.84M | 9.94M | 9.9M | 9.71M | 12.38M | 9.69M | 3.63M | 2.13M | 1.66M |
| Other Working Capital | -27.49M | -26.55M | 25.74M | 729K | -1.96M | -557K | 3.66M | -9.08M | -26.47M | -2.72M | 34.98M | -3.74M | 8.4M | 6.43M | 1.05M | 546K | 1.63M |
| Other Non-Cash Items | 19.29M | 9.08M | 57.75M | -33.87M | -16.79M | 1.02M | 1.25M | 1.01M | -2.32M | 1.3M | 177K | 287K | 226K | 359K | 110K | 23K | -88K |
| Deferred Income Tax | -11.42M | n/a | -93.65M | -107K | -735K | -925K | 653K | n/a | n/a | n/a | n/a | n/a | n/a | 100K | 84K | -9K | 10K |
| Change in Working Capital | -58.96M | -53.97M | 21M | -2.76M | -3M | 5.67M | -6.03M | -18M | -31.39M | -772K | 33.73M | 1M | -12M | 2.86M | 4.94M | 323K | 1.63M |
| Operating Cash Flow | -259.17M | -263.21M | -111.18M | 19.5M | -78.31M | -66.43M | -67.52M | -67.93M | -47.89M | -51.47M | -29.83M | -76.82M | -102.97M | -122M | -74.84M | -38.3M | -16.73M |
| Capital Expenditures | -8.84M | -16.93M | -5.93M | -1.04M | -2.84M | -1.85M | -10.43M | -8.21M | -3.01M | -1.61M | -909K | -1.7M | -9.28M | -5.26M | -5.18M | -5.7M | -3.05M |
| Acquisitions | -102K | 179K | -319.79M | 218.28M | -64.88M | n/a | 41K | 10K | 36K | n/a | n/a | -61.79M | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -756.57M | -442.79M | -988.05M | -373.28M | -57.73M | -122.18M | -86.34M | -95.85M | -84.58M | -126.41M | -201.55M | -87.89M | -264.07M | -180.96M | -25.43M | -36.38M | -53.96M |
| Sales Maturities Of Investments | 770.12M | 575.8M | 635.24M | 155M | 122.61M | 85.62M | 95.18M | 89.18M | 100.66M | 147.59M | 169.34M | 151.38M | 279.8M | 47.97M | 49.2M | 31.69M | 38.67M |
| Other Investing Acitivies | n/a | -179K | -352.81M | -218.28M | 64.88M | -36.56M | 41K | 10K | -4.5M | 21.17M | -32.21M | 61.79M | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 4.6M | 116.08M | -678.53M | -219.32M | 62.05M | -38.41M | -1.55M | -14.86M | 8.61M | 19.56M | -33.12M | 61.79M | 6.45M | -138.25M | 18.59M | -10.39M | -18.34M |
| Debt Repayment | -1.84M | -1.61M | 895.17M | -16M | n/a | n/a | -4.5M | n/a | n/a | n/a | 19.77M | n/a | n/a | n/a | -1.3M | -400K | -392K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8K | n/a | -5K |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -78.47M | 11.23M | -20.44M | 80.36M | 18M | 9.65M | 8.91M | 7.73M | 7.36M | 3.97M | 3.08M | n/a | n/a | 107.88M | 68.32M | 120.33M | 172K |
| Financial Cash Flow | 108.89M | 9.62M | 1.17B | 251.84M | 26.55M | 107.18M | 68.81M | 65.93M | 36.46M | 41.99M | 42.77M | 2.71M | 7.74M | 318.66M | 67.01M | 119.93M | -225K |
| Net Cash Flow | -148.4M | -137.51M | 379.87M | 52.02M | 10.28M | 2.34M | -258K | -16.86M | -2.82M | 10.09M | -20.18M | -12.32M | -88.78M | 58.42M | 10.77M | 71.23M | -35.3M |
| Free Cash Flow | -268.02M | -280.14M | -117.11M | 18.46M | -81.15M | -68.28M | -77.95M | -76.14M | -50.9M | -53.08M | -30.74M | -78.53M | -112.26M | -127.25M | -80.02M | -44.01M | -19.78M |